Anbio Biotechnology revenue was $8.65M for the trailing 12 months ending Dec 31, 2025, with 162.5% growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, NNNN annual revenue was $8.6M, with 5.6% growth year-over-year.
NNNN past revenue growth
How has NNNN's revenue growth performed historically?
Anbio Biotechnology (NASDAQ: NNNN) reported Q4 2025 revenue of N/A up N/A year over year. In the same quarter last year, Anbio Biotechnology's revenue was N/A.
What was Anbio Biotechnology's revenue in 2025?
Anbio Biotechnology's annual revenue for the twelve months ending Dec 31, 2025 was $8.65 million, a 5.64% increase year over year.
How much does Anbio Biotechnology make in a day?
Based on Anbio Biotechnology annual revenue for the past three years, NNNN makes an average of $21,501.35 per day.
What was Anbio Biotechnology's annual revenue growth in the past year?
As of Q2 2026, Anbio Biotechnology's revenue has grown 5.64% year over year. This is 7.92 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 13.56%. Anbio Biotechnology's revenue in the past year totaled $8.65 million.
How much does Anbio Biotechnology make in a year?
Anbio Biotechnology's revenue by year for the past three years is:
Anbio Biotechnology's revenue for the twelve months ending Dec 31, 2025 was $8.65 million, a 5.64% increase year over year.
Anbio Biotechnology's annual revenue for Dec 31, 2024 was $8.19 million, a 21.95% increase from 2023.
Anbio Biotechnology's annual revenue for 2023 was $6.71 million, a 71.49% decrease from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.